Connectyx Technologies (PK) Stock Price - CTYX

0.0089
0.00 (0.0%)
0.0089
Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Connectyx Technologies Holdings Group Inc New (PK) CTYX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.0089 0.00 0.00 0.00 0.0089 20:00:00
Bid Price Ask Price Spread Spread % News
0.0077 0.0089 0.0012 13.48% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.0089 USD

Connectyx Technologies (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.87M 322.80M 188.71M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.03k $ - 0.00% - -

more financials information »

Connectyx Technologies (PK) News

Date Time Source News Article
4/16/202008:00InvestorsHub NewsWireCannabis and CBD Stocks are Old News, The Next Hot..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTYX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.00950.00980.00730.00866432,315,860-0.0006-6.32%
1 Month0.00910.01080.00550.0080462,970,229-0.0002-2.2%
3 Months0.01490.02850.0040.01353488,043,935-0.006-40.27%
6 Months0.00010.02850.00010.00931219,618,5350.00888,800.0%
1 Year0.00010.02850.0000010.00895919,205,5330.00888,800.0%
3 Years0.0000010.02850.0000010.00892867,971,8520.0089889,900.0%
5 Years0.00150.02850.0000010.00889267,258,8430.0074493.33%

Connectyx Technologies (PK) Description

Connectyx Technologies Holdings Group, Inc. is a development stage biomedical company that seeks to develop, in-license, sub-license and bring to market products in both the Pharmaceutical and Medical Device space. The Company focuses on products that are targeted at FDA-defined "Orphan Diseases" with patient populations under 200,000 in the United States. The company leverages management's experience and business relationships with Life Science development associations as well as Life Science-focused venture capital firms to acquire Life Science candidates that fit within the company's business model. The company has established a scientific advisory board with a successful track record of bringing pharmaceuticals to market.
Your Recent History
USOTC
CTYX
Connectyx ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200602 11:34:52